Top Markets
#1 0G 0G +32.75%
#2 Zora Zora +23.49%
#3 Nockchain Nockchain +20.21%
#4 Fake World Assets Fake World Assets +19.05%
#5 Axelar Axelar +18.61%
#6 Full Moon Full Moon +17.70%
#7 Merlin's Seal BTC Merlin's Seal BTC +15.95%
#8 Notcoin Notcoin +15.90%
#9 ADO Protocol ADO Protocol +15.68%
#10 SAFEcoin SAFEcoin +14.51%
Coin of the day
0G 0G
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Silverback Therapeutics, Inc. Silverback Therapeutics, Inc.

Silverback Therapeutics, Inc.

SBTX
Classement en actions #12782
Silverback Therapeutics, Inc. operates as a biotechnology firm dedicated to... Silverback Therapeutics, Inc. operates as a biotechnology firm dedicated to devising tissue-specific drug candidates aimed at addressing chronic viral infections, various cancers, and other significant medical conditions. Among its pipeline, SBT8230 stands out as a treatment for chronic hepatitis B virus, working by stimulating an antiviral immune response through the precise activation of TLR8 within the liver. The company was founded in 2016 and maintains its principal offices in Seattle, Washington.
Prix de l'action
$5.87
Dernière synchronisation: 2022-11-08
Capitalisation boursière
$550.43M
Changement (1 jour)
1.03%
Changement (1 an)
0.00%
Pays
US
Échange Silverback Therapeutics, Inc. (SBTX)

Catégorie

Healthcare
Ratio P/S pour Silverback Therapeutics, Inc. (SBTX)
Ratio P/S au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de Silverback Therapeutics, Inc., le ratio cours/ventes actuel (TTM) est 0. À la fin de 2026, le ratio P/S était de 0.
Historique du ratio P/S pour Silverback Therapeutics, Inc. de 2026 à 2026
Ratio P/S à la fin de chaque année
Année Ratio P/S Changez
Pas assez de données pour les dates fournies.
Ratio P/S pour des entreprises similaires ou concurrentes
Entreprise Ratio P/S Différence de Ratio P/S Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.95 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
11.28 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH